Healthy men help uncover drug interactions in Early-Stage trial
NCT ID NCT06070610
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study looked at how taking multiple doses of an experimental drug (BI 1015550) changes the way the body handles two approved lung medications (nintedanib and pirfenidone). Fourteen healthy men received the drugs in a fixed order, and researchers measured drug levels in their blood. The goal was to see if BI 1015550 speeds up or slows down the breakdown of these medicines, which helps guide future dosing in patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany